Aurélie Stanislas

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study

Élodie Elkaim, Bénédicte Neven, Julie Bruneau et al. · Journal of Allergy and Clinical Immunology · 2016 · 285 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi et al. · Frontiers in Immunology · 2018 · 182 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion

Chantal Lagresle‐Peyrou, François Lefrère, Elisa Magrin et al. · Haematologica · 2018 · 110 citations · Full text

Medicine, Cell Biology, Hematology +17

Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory

Jean‐Antoine Ribeil, Myriam Labopin, Aurélie Stanislas et al. · American Journal of Hematology · 2018 · 19 citations · Full text

Medicine, Hematology, Maternal Health +17

Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients

Gerhard Kindle, Mickaël Alligon, Michael H. Albert et al. · Journal of Human Immunity · 2025 · 19 citations · Full text

Life Sciences, Immunology, Pediatrics +11